On one hand, beyond its capacity to convert pro-oxidant heme into antioxidant degradation products, HO-1 induction in Parkinson's disease enhances α-synuclein proteasomal degradation, prevents dopaminergic neuron death by promoting neurotrophic factor synthesis, and augments antioxidant responses [58–60]. This evidence concerns the gene HMOX1 and Parkinson disease.